Identification of novel drug combinations to target molecular pathways involved in breast cancer

被引：0
|
作者：
Petroni, Vanessa [1 ]
Podesta, Marie Therese Camilleri [1 ]
Fenech, Anthony George [1 ]
Grech, Godfrey [1 ]
机构：
[1] Univ Malta, Msida, Malta
来源：
MOLECULAR CANCER THERAPEUTICS | 2015年 / 14卷 / 07期
关键词：
D O I：
10.1158/1538-8514.PI3K14-B22
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B22
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Novel drug target may assist treatment of drug-resistant breast cancer
    不详
    [J]. PERSONALIZED MEDICINE, 2011, 8 (04) : 389 - 390
  • [32] Systematic identification of pathways associated with antibody drug conjugate sensitivity in breast cancer
    Wu, Bogang
    Sun, Sheng
    Thimmiah, Nayana
    Nagayama, Aiko
    Coates, James T.
    Liu, Ting
    Thant, Win
    Bitman, Elena
    Li, David
    Doench, John
    Bardia, Aditya
    Ellisen, Leif W.
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [33] Systematic identification of pathways associated with antibody drug conjugate sensitivity in breast cancer
    Wu, Bogang
    Sun, Sheng
    Thimmiah, Nayana
    Nagayama, Aiko
    Coates, James
    Thant, Win
    Li, David
    Doench, John
    Bardia, Aditya
    Ellisen, Leif
    [J]. CANCER RESEARCH, 2023, 83 (07)
  • [34] Identification of Novel Inhibitors for ERα Target of Breast Cancer By In Silico Approach
    Alagarsamy, Veerachamy
    Sulthana, Mohaideen Thasthagir
    Narendhar, Bandi
    Solomon, Viswas Raja
    Gobinath, Manavalan
    Satishchandra, Aithamraju
    Sangeetha, Dubudam
    Murugesan, Sankaraanarayanan
    [J]. CURRENT COMPUTER-AIDED DRUG DESIGN, 2024,
  • [35] Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
    Wali, Vikram B.
    Patwardhan, Gauri A.
    Pelekanou, Vasiliki
    Karn, Thomas
    Cao, Jian
    Ocana, Alberto
    Yan, Qin
    Nelson, Bryce
    Hatzis, Christos
    Pusztai, Lajos
    [J]. SCIENTIFIC REPORTS, 2019, 9 (1)
  • [36] Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer
    Vikram B. Wali
    Gauri A. Patwardhan
    Vasiliki Pelekanou
    Thomas Karn
    Jian Cao
    Alberto Ocana
    Qin Yan
    Bryce Nelson
    Christos Hatzis
    Lajos Pusztai
    [J]. Scientific Reports, 9
  • [37] Identification of miRNAs and Their Associated Target Genes Involved in Endocrine Resistance in Breast Cancer.
    Healy, N. A.
    Creighton, C. J.
    Fu, X.
    Tsimelzon, A.
    Hilsenbeck, S. G.
    Miller, N.
    Kerin, M. J.
    Osborne, C. K.
    Schiff, R.
    [J]. CANCER RESEARCH, 2011, 71
  • [38] Delineating novel molecular pathways driving endocrine resistance in breast cancer
    Bosch, A.
    Staaf, J.
    Akrap, N.
    Kaminska, K. K.
    Borgquist, S.
    Borg, A.
    Honeth, G.
    [J]. CANCER RESEARCH, 2017, 77
  • [39] Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer
    Suman, Shankar
    Sharma, Pradeep Kumar
    Rai, Girish
    Mishra, Sanjay
    Arora, Deepika
    Gupta, Prachi
    Shukla, Yogeshwer
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 472 (03) : 401 - 409
  • [40] Cancer drug target identification and node-level analysis of the network of MAPK pathways
    Aksam V.K.M.
    Chandrasekaran V.M.
    Pandurangan S.
    [J]. Network Modeling Analysis in Health Informatics and Bioinformatics, 2018, 7 (01)
12345